Shares of Edwards Lifesciences Corp (NYSE:EW) have been assigned an average recommendation of “Buy” from the twenty-four brokerages that are presently covering the stock. One analyst has rated the stock with a sell recommendation, five have issued a hold recommendation and seventeen have issued a buy recommendation on the company. The average 1-year price objective […]
